Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.02.12
关于召开2018年第二次暂时股东大会的通知通告
2018.02.12
使用超募资金收购深圳市多普乐实业生长有限公司100%股权的通告
2018.02.12
北京市中伦(深圳)状师事务所关于公司购置资产暨关联生意的执法意见书
2018.02.12
深圳市多普乐实业生长有限公司审计报告
2018.02.12
拟收购股权所涉及深圳市多普乐实业生长有限公司股东所有权益评估报告
2018.02.12
中天堂富证券有限公司关于公司使用超募资金收购深圳市多普乐实业生长有限公司100%股权...
2018.02.07
团结信用评级有限公司关于公司2017年度业绩预减的关注通告
2018.02.02
2018年第一次暂时股东大会的执法意见书
2018.02.02
2018年第一次暂时股东大会决议通告
2018.01.30
2017年度业绩预告修正通告
第一页
上一页
61
62
63
64
65
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】